|Table of Contents|

Research progress of HPV-associated bladder cancer

Journal Of Modern Oncology[ISSN:1672-4992/CN:61-1415/R]

Issue:
2023 23
Page:
4481-4485
Research Field:
Publishing date:

Info

Title:
Research progress of HPV-associated bladder cancer
Author(s):
LI Fei; PANG Lei; WEN Xiaodong; CHAI Hongqiang; WU Ming; SHAO Jinkai
Department of Urology,the Fifth Clinical Medical College of Shanxi Medical University,Shanxi Taiyuan 030012,China.
Keywords:
human papillomavirus; bladder cancer; grading; staging
PACS:
R737.14
DOI:
10.3969/j.issn.1672-4992.2023.23.036
Abstract:
Human papillomavirus（HPV） is associated with many diseases.In particular,high-risk HPV is closely associated with many types of cancers,such as head and neck squamous cell carcinoma and anogenital cancer.In recent years,the incidence of bladder cancer has shown an increasing trend year by year,and a large number of studies have confirmed that HPV played a pathogenic role in the etiology of bladder cancer,especially the high-risk HPV16 has been recognized as a potential risk factor for urogenital cancer.In this review,we will summarize the studies related to the etiological role of HPV in different types of bladder cancer and its effect on the grade and stage of bladder cancer,in order to provide a scientific basis for the diagnosis,prevention and treatment of HPV related bladder cancer in the future.

References:

［1］ SUNG H,FERLAY J,SIEGEL RL,et al.Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries［J］.CA Cancer J Clin,2021,71(3):209-249.
［2］ 刘宗超,李哲轩,张阳,等.2020全球癌症统计报告解读［J］.肿瘤综合治疗电子杂志,2021,7(02):1-14. LIU Zongchao,LI Zhexuan,ZHANG Yang,et al.Interpretation of the 2020 global cancer statistics report［J］.Electronic Journal of Comprehensive Treatment of Cancer,2021,7(02):1-14.
［3］ 黄海超,张鹏,邢金春,等.儿童及青少年膀胱癌临床特点与发病机制研究(附1例罕见17岁女性膀胱癌报告)［J］.临床泌尿外科杂志,2017,32(05):386-388. HUANG Haichao,ZHANG Peng,XING Jinchun,et al.Clinical features and pathogenesis of bladder cancer in children and adolescents (a report of a rare 17-year-old female with bladder cancer)［J］.Journal of Clinical Urology,2017,32(05):386-388.
［4］ OHADIAN MOGHADAM S,NOWROOZI MR.Toll-like receptors:The role in bladder cancer development,progression and immunotherapy［J］.Scand J Immunol,2019,90(6):e12818.
［5］ SKINNER HD,STURGIS EM,KLOPP AH,et al.Clinical characteristics of patients with multiple potentially human papillomavirus-related malignancies［J］.Head Neck,2014,36:819-825.
［6］ KRZOWSKA-FIRYCH J,LUCAS G,LUCAS C,et al.An overview of human papillomavirus (HPV) as an etiological factor of the anal cancer［J］.Infect Public Health,2019,12(1):1-6.
［7］ MIRGHANI H,BELLERA C,DELAYE J,et al.Prevalence and characteristics of HPV-driven oropharyngeal cancer in France［J］.Cancer Epidemiol,2019,61:89-94.
［8］ DE SANJOSE S,SERRANO B,TOUS S,et al.Burden of human apillomavirus (HPV)-related cancers attributable to HPVs 6/11/16/18/31/33/45/52 and 58［J］.JNCI Cancer Spectr,2019,2(4):pky045.
［9］ ST LAURENT J,LUCKETT R,FELDMAN S.HPV vaccination and the effects on rates of HPV-related cancers［J］.Curr Probl Cancer,2018,42(5):493-506.
［10］ ABDOLLAHZADEH P,MADANI SH,KHAZAEI S,et al.Association between human papillomavirus and transitional cell carcinoma of the bladder［J］.Urology Journal,2017,14(6):5047-5050.
［11］ TOMMASINO M.The human papillomavirus family and its role in carcinogenesis［J］.Semin Cancer Biol,2014,26:13-21.
［12］ KHAN MJ,CASTLE PE,LORINCZ AT,et al.The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice［J］.J Natl Cancer Inst,2005,97(14):1072-1079.
［13］ SHIGEHARA K,KAWAGUCHI S,SASAGAWA T,et al.Etiological correlation of human papillomavirus infection in the development of female bladder tumor［J］.APMIS,2013,121(12):1169-1176.
［14］ SERRANO B,BROTONS M,BOSCH FX,et al.Epidemiology and burden of HPV-related disease［J］.Best Pract Res Clin Obstet Gynaecol,2018,47:14-26.
［15］ 张勤,王冬.高危型HPV感染在宫颈癌前病变、宫颈癌中的临床意义［J］.现代肿瘤医学，2020,28(05):788-791. ZHANG Qin,WANG Dong.Clinical significance of high-risk HPV testing for cervical precancerous lesions and cervical cancer［J］.Modern Oncology，2020,28(05):788-791.
［16］ 郑歆,汪代杰.HPV阳性口咽癌的研究现状与进展［J］.现代肿瘤医学，2021,29(04):704-707. ZHENG Xin,WANG Daijie.Research status and progress of HPV-positive oropharyngeal cancer［J］.Modern Oncology，2021,29(04):704-707.
［17］ PLUMMERl M,DE MARTEL C,VIGNAT J,et al.Global burden of cancers attributable to infections in 2012:a synthetic analysis［J］.Lancet Glob Health,2016,4(9):609-616.
［18］ 于淼,孙峥嵘.人乳头瘤病毒致癌关键因素的研究进展［J］.现代肿瘤医学,2020,28(05):851-854. YU Miao,SUN Zhengrong.Development of key oncogenic factors for human papillomavirus［J］.Modern Oncology,2020,28(05):851-854.
［19］ FARAJI F,ZAIDI M,FAKHRY C,et al.Molecular mechanisms of human papillomavirus-related carcinogenesis in head and neck cancer［J］.Microbes Infect,2017,19(9-10):464-475.
［20］ SPEEL EJ.HPV integration in head and neck squamous cell carcinomas:Cause and consequence［J］.Recent Results Cancer Res,2017,206:57-72.
［21］ 刘淼,孙峥嵘.高危型人乳头瘤病毒癌基因E6和E7调节细胞作用靶点的研究进展［J］.现代肿瘤医学,2022,30(04):748-752. LIU Miao,SUN Zhengrong.Regulation of cellular targets by high risk human papillomavirus oncogenes E6 and E7［J］.Modern Oncology,2022,30(04):748-752.
［22］ 赵兴荣,车团结,王锦明,等.人膀胱移行细胞癌HPV16/18感染与MAGE-A1基因启动子去甲基化状态的研究［J］.实用癌症杂志,2009,24(05):462-465. ZHAO Xingrong,CHE Tuanjie,WANG Jinming,et al.HPV16/18 infection and MAGE-A1 promoter demethylation status in human bladder transitional cell carcinoma［J］.Journal of Practical Cancer,2009,24(05):462-465.
［23］ VISALLI G,FACCIOLA A,D'ALEO F,et al.HPV and urinary bladder carcinoma:a review of the literature［J］.World Cancer Research Journal,2018,5(1):e1038.
［24］ KITAMURA T,YOGO Y,UEKI T,et al.Presence of human papillomavirus type 16 genome in bladder carcinoma in situ of a patient with mild immunodeficiency［J］.Cancer Research,1988,48(24_Part_1):7207-7211.
［25］ WIWANITKIT V.Urinary bladder carcinoma and human papilloma virus infection,an appraisal of risk［J］.Asian Pacific Journal of Cancer Prevention,2005,6(2):217-218.
［26］ GUTIERREZ J,JIMENEZ A,YUAN D,et al.Meta-analysis of studies analyzing the relationship between bladder cancer and infection by human papillomavirus［J］.Journal of Urology,2006,176(6):2474-2481.
［27］ LI N,YANG L,ZHANG Y,et al.Human papillomavirus infection and bladder cancer risk:a meta-analysis［J］.J Infect Dis,2011,204(2):217-223.
［28］ JIMENEZ-PACHECO A,EXPOSITO-RUIZ M,ARRABAL-POLO MA,et al.Meta-analysis of studies analyzing the role of human papillomavirus in the development of bladder carcinoma［J］.Korean J Urol,2012，53(4):240-247.
［29］ KHATAMI A,SALAVATIHA Z,RAZIZADEH MH.Bladder cancer and human papillomavirus association:a systematic review and meta-analysis［J］.Infect Agent Cancer,2022,17(1):3.
［30］ LOPEZ-BELTRAN A.Bladder cancer:clinical and pathological profile［J］.Scand J Urol Nephrol Suppl,2008,218:95-109.
［31］ SHIGEHARA K,SASAGAWA T,KAWAGUCHI S,et al.Etiologic role of human papillomavirus infection in bladder carcinoma［J］.Cancer,2011,117(10):2067-2076.
［32］ SARIER M,SEPIN N,KELES Y,et al.Is there any association between urothelial carcinoma of the bladder and human papillomavirus? A case-control study［J］.Urol Int,2020,104(1-2):81-86.
［33］ 杜均祥,张征荣,谢云,等.高危型人乳头瘤病毒与膀胱癌发生的关系［J］.国际泌尿系统杂志,2021,41(03):418-422. DU Junxiang,ZHANG Zhengrong,XIE Yun,et al.Association between high risk human papillomavirus and bladder carcinogenesis［J］.Int J Urology,2021,41(03):418-422.
［34］ MUSANGILE FY,MATSUZAKI L,OKODO M,et al.Detection of HPV infection in urothelial carcinoma using RNAscope:Clinicopathological characterization［J］.Cancer Med,2021,10(16):5534-5544.
［35］ 马榕,黄如,郭帅,等.HPV-16型在膀胱尿路上皮细胞癌人群中的表达及临床意义［J］.现代泌尿生殖肿瘤杂志,2018,10(05):288-290. MA Rong,HUANG Ru,GUO Shuai,et al.Expression and clinical significance of HPV-16 in human bladder urothelial cell carcinoma population［J］.Modern Journal of Genitourinary Oncology,2018,10(05):288-290.
［36］ MOSTAFA MH,SHEWEITA SA,O' CONNOR PJ.Relationship between schistosomiasis and bladder cancer［J］.Clin Microbiol Rev,1999,12(1):97-111.
［37］ GUO CC,GOMEZ E,TAMBOIL P,et al.Squamous cell carcinoma of the urinary bladder:a clinicopathologic and immunohistochemical study of 16 cases［J］.Hum Pathol,2009,40(10):1448-1452.
［38］ WESTENEND PJ,STOOP JA,HENDRIKS JG.Human papillomaviruses 6/11,16/18 and 31/33/51 are not associated with squamous cell carcinoma of the urinary bladder［J］.BJU Int,2001,88(3):198-201.
［39］ GORDETSKY J,SPIEKER AJ,PENA MDCR,et al.Squamous cell carcinoma of the bladder is not associated with high-risk HPV［J］.Urology,2020,144:158-163.
［40］ ALEXANDER RE,HU Y,KUM JB,et al.P16 expression is not associated with human papillomavirus in urinary bladder squamous cell carcinoma［J］.Mod Pathol,2012,25(11):1526-1533.
［41］ ALEXANDER RE,WILLIAMSON SR,RICHEY J,et al.The expression patterns of p53 and p16 and an analysis of a possible role of HPV in primary adenocarcinoma of the urinary bladder［J］.PLoS One,2014,9(4):e95724.
［42］ TENTI P,ZAPPATORE R,ROMAGNOLI S,et al.P53 overexpression and human papillomavirus infection in transitional cell carcinoma of the urinary bladder:correlation with histological parameters［J］.J Pathol,1996,178(1):65-70.
［43］ JAVANMARD B,BARGHI MR,AMANI D,et al.Human papilloma virus DNA in tumor tissue and urine in different stage of bladder cancer［J］.Urol J,2019,16(4):352-356.
［44］ MOONEN PM,BAKKERS JM,KIEMENEY LS,et al.Human papilloma virus DNA and p53 mutation analysis on bladder washes in relation to clinical outcome of bladder cancer［J］.Eur Urol,2007,52(2):464-468.

Memo

Memo:
山西省卫生健康委员会科研基金资助项目（编号：2022073）
Last Update: 2023-10-31